INSP Relative Valuation
INSP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, INSP is overvalued; if below, it's undervalued.
Historical Valuation
Inspire Medical Systems Inc (INSP) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.08 is considered Undervalued compared with the five-year average of -7.19. The fair price of Inspire Medical Systems Inc (INSP) is between 190.54 to 584.35 according to relative valuation methord. Compared to the current price of 127.18 USD , Inspire Medical Systems Inc is Undervalued By 33.25%.
Relative Value
Fair Zone
190.54-584.35
Current Price：127.18
33.25%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
6.33
P/B
Median3y
12.11
Median5y
16.71
1.97
FCF Yield
Median3y
0.25
Median5y
-0.22
Competitors Valuation Multiple
The average P/S ratio for INSP's competitors is 3.92, providing a benchmark for relative valuation. Inspire Medical Systems Inc Corp (INSP) exhibits a P/S ratio of 4.08, which is 4.19% above the industry average. Given its robust revenue growth of 22.75%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Inspire Medical Systems Inc (INSP) currently overvalued or undervalued?
What is Inspire Medical Systems Inc (INSP) fair value?
How does INSP's valuation metrics compare to the industry average?
What is the current P/B ratio for Inspire Medical Systems Inc (INSP) as of Jun 16 2025?
What is the current FCF Yield for Inspire Medical Systems Inc (INSP) as of Jun 16 2025?
What is the current Forward P/E ratio for Inspire Medical Systems Inc (INSP) as of Jun 16 2025?